Diagnostics

BioTech Breakthrough Acknowledges Champions Oncology Innovation with the “Contract Research and Development Innovation Award”

Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the World HACKENSACK, NJ / ACCESS Newswire / November...

Zomedica Announces “Third Friday at Four” Webinar on November 20, 2026: The People Behind Zomedica – Seven Guiding Principles in Action, and Q3 Financial Results

November session will introduce the experienced team behind Zomedica's seven guiding principles, from R&D and manufacturing to finance and the...

Roche presents new data across pharmaceuticals and diagnostics from its growing Alzheimer’s disease portfolio at CTAD 2026

Updated Phase Ib/IIa Brainshuttle™ AD study data for trontinemab demonstrating rapid amyloid removal dynamics and changes in key biomarkers Phase III...

OraSure Announces Third Quarter 2026 Financial Results; Strategic Execution Drives Double-Digit Year-Over-Year Growth and Margin Expansion

14% year-over-year revenue growth in the quarter highlights effectiveness of return-to-growth strategyGAAP gross margin improved by over 170 bps vs....

WELL Health Reports Record Q3-2026 Revenue; Canadian Patient Services Adjusted EBITDA Up 82%, Reaching $100 Million Annualized Run-Rate Milestone One Quarter Ahead of Plan

WELL achieved quarterly revenue of $407.4 million in Q3-2026, an increase of 12% compared to Q3-2025, driven by strong growth...

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity

Zomedica surpasses $9 million in quarterly revenue for the second quarter in a row while extending its record of consecutive...

Dario Names Veteran Healthcare Executive John R. Palumbo Chairman of the Board as Company Positions Itself to Lead the Convergence of Consumer and Payer-Funded Care

error: Content is protected !!